Nu Skin (NUS) director awarded 26,643 Class A shares, now holds 116,827

Rhea-AI Filing Summary

Thomas Pisano R. reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. director Thomas R. Pisano received a grant of Class A Common Stock as equity compensation. On June 1, 2026, he was awarded 26,643 shares at no purchase price, reflecting a stock-based award rather than an open-market buy. Following this grant, he directly holds 116,827 shares of Nu Skin Class A Common Stock, indicating the transaction increased his equity stake through a routine compensation-related award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Thomas Pisano R.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	26,643	$0.00	--

Holdings After Transaction: Class A Common Stock — 116,827 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 26,643 shares Grant price per share: $0.00 per share Shares owned after grant: 116,827 shares +1 more

4 metrics

Shares granted 26,643 shares Grant of Class A Common Stock on June 1, 2026

Grant price per share $0.00 per share Reported transaction price for stock award

Shares owned after grant 116,827 shares Total direct holdings following the transaction

Transaction code A Classified as Grant, award, or other acquisition

Key Terms

Class A Common Stock, Grant, award, or other acquisition, non-derivative, direct

4 terms

Class A Common Stock financial

"Security title reported as Class A Common Stock for the grant"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition"

non-derivative financial

"Transaction type is labeled non-derivative for the stock grant"

direct financial

"Ownership type following the transaction is shown as direct"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas Pisano R.

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UTAH 84601

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/01/2026		A		26,643	A	$0.00	116,827	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gregory Belliston as Attorney-in-Fact for Thomas R. Pisano	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Nu Skin (NUS) director Thomas R. Pisano report on this Form 4?

Director Thomas R. Pisano reported receiving a stock grant of Class A Common Stock. He was awarded 26,643 shares as compensation, rather than buying them in the market, increasing his direct holdings in Nu Skin Enterprises, Inc.

How many Nu Skin (NUS) shares were granted to Thomas R. Pisano?

Thomas R. Pisano was granted 26,643 shares of Nu Skin Class A Common Stock. This award was reported as a non-derivative grant transaction, classified as a “Grant, award, or other acquisition” under SEC transaction code A.

At what price were the Nu Skin (NUS) shares granted to Thomas R. Pisano?

The 26,643 Nu Skin Class A shares were granted at a reported price of $0.00 per share. This indicates a stock-based compensation award, not an open-market purchase, consistent with the Form 4 classification as a grant or award.

How many Nu Skin (NUS) shares does Thomas R. Pisano own after this grant?

After the reported grant, Thomas R. Pisano directly holds 116,827 shares of Nu Skin Class A Common Stock. This total reflects his position following the 26,643-share compensation award disclosed in the Form 4 filing.

Was the Nu Skin (NUS) Form 4 transaction a market buy or a compensation grant?

The transaction was a compensation grant, not a market buy. It is coded as transaction type A, “Grant, award, or other acquisition,” with a price of $0.00 per share, indicating shares issued as equity compensation to the director.